Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion type Assertion NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_head.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion description "[Truncation of 14-amino acid residues of the cytoplasmic domain of F protein resulted in dramatic enhancement of cell-killing activities of oncolytic SeV, and the combination with replacement of the trypsin cleavage site with the new urokinase type plasminogen activator (uPA)-sensitive sequence (SGRS) led a variety of human tumors, including prostate (PC-3), renal (CAKI-I), pancreatic (BxPC3) and lung (PC14) cancers, to extensive death through massive cell-to-cell spreading without significant dissemination to the surrounding noncancerous tissue in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_provenance.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion evidence source_evidence_literature NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_provenance.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion SIO_000772 19037241 NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_provenance.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion wasDerivedFrom befree-20140225 NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_provenance.
- NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_assertion wasGeneratedBy ECO_0000203 NP547306.RAEYXXmgdx-msAMU_u1eIcUcMv87F3R3Fog-_mUYjCldg130_provenance.